Entrada Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$12.03

+0.56 (+4.88%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +50.0% upside

Low Target $12.20

Average Target $18.04

High Target $27.27

Current Price $12.03

Current
$12.03

Target
$18.04

$12.20 $18.04 avg $27.27

Scenario Analysis

Bear Case

$12.20

1.4%

Low target

Base Case

$18.04

+50.0%

Avg target

Bull Case

$27.27

+126.7%

High target

Risk/Reward

89.6x

Highly favorable

Price in Context

52-Week High

$13.66

-11.9% from high

52-Week Low

$4.93

+144.0% from low

Target vs 52W High

$18.04

+32.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%